pneumonia is the leading cause of morbidity and mortality among children <5 years of age globally. pneumococcal conjugate vaccines (pCVs) are known to provide protection against vaccine serotype pneumococ-cal pneumonia; uncertainty exists regarding the optimum pCV dosing schedule. Methods: We conducted a systematic review of studies published from 1994 to 2010 (supplemented post hoc with studies from 2011) documenting the effect of pCV dosing schedules on clinical and radiologically confirmed pneumonia, pneumococcal pneumonia and empyema among children of ages targeted to receive vaccine. Data on 2- and 3-dose schedules were included. percent change of pneumonia incidence rates from baseline to most recent year post-pCV introduction was ...
Context The effects of reduced-dose schedules of 7-valent pneumococcal conjugate vaccine (PCV-7) on ...
Context The effects of reduced-dose schedules of 7-valent pneumococcal conjugate vaccine (PCV-7) on ...
BACKGROUND: Pneumococcal conjugate vaccines (PCV) were first licensed for use with 3 primary doses ...
Background: pneumococcal conjugate vaccines (pCV) reduce naso-pharyngeal carriage of vaccine type (V...
Background: This systematic review and meta-analysis aimed at summarizing available data on the impa...
Abstract Rationale The effectiveness of universal immunisation with pneumococcal conjugate vaccine (...
Since second generation pneumococcal conjugate vaccines (PCVs) targeting 10 and 13 serotypes became ...
Background Pneumococcal conjugate vaccines (PCV) were first licensed for use with 3 primary doses...
Madhi et al.1 write that the pneumococcal conjugate vaccine (PCV) is an effective instrument for pne...
Background: Pneumonia, caused by Streptococcus pneumoniae, is a major cause of morbidity and mortali...
Background: Pneumonia, caused by Streptococcus pneumoniae, is a major cause of morbidity and mortali...
BACKGROUND: Pneumococcal conjugate vaccines (PCV) were first licensed for use with 3 primary doses i...
BACKGROUND: Pneumococcal conjugate vaccines (PCV) reduce disease due to Streptococcus pneumoniae. We...
Context The effects of reduced-dose schedules of 7-valent pneumococcal conjugate vaccine (PCV-7) on ...
BACKGROUND: Pneumococcal conjugate vaccines (PCV) were first licensed for use with 3 primary doses ...
Context The effects of reduced-dose schedules of 7-valent pneumococcal conjugate vaccine (PCV-7) on ...
Context The effects of reduced-dose schedules of 7-valent pneumococcal conjugate vaccine (PCV-7) on ...
BACKGROUND: Pneumococcal conjugate vaccines (PCV) were first licensed for use with 3 primary doses ...
Background: pneumococcal conjugate vaccines (pCV) reduce naso-pharyngeal carriage of vaccine type (V...
Background: This systematic review and meta-analysis aimed at summarizing available data on the impa...
Abstract Rationale The effectiveness of universal immunisation with pneumococcal conjugate vaccine (...
Since second generation pneumococcal conjugate vaccines (PCVs) targeting 10 and 13 serotypes became ...
Background Pneumococcal conjugate vaccines (PCV) were first licensed for use with 3 primary doses...
Madhi et al.1 write that the pneumococcal conjugate vaccine (PCV) is an effective instrument for pne...
Background: Pneumonia, caused by Streptococcus pneumoniae, is a major cause of morbidity and mortali...
Background: Pneumonia, caused by Streptococcus pneumoniae, is a major cause of morbidity and mortali...
BACKGROUND: Pneumococcal conjugate vaccines (PCV) were first licensed for use with 3 primary doses i...
BACKGROUND: Pneumococcal conjugate vaccines (PCV) reduce disease due to Streptococcus pneumoniae. We...
Context The effects of reduced-dose schedules of 7-valent pneumococcal conjugate vaccine (PCV-7) on ...
BACKGROUND: Pneumococcal conjugate vaccines (PCV) were first licensed for use with 3 primary doses ...
Context The effects of reduced-dose schedules of 7-valent pneumococcal conjugate vaccine (PCV-7) on ...
Context The effects of reduced-dose schedules of 7-valent pneumococcal conjugate vaccine (PCV-7) on ...
BACKGROUND: Pneumococcal conjugate vaccines (PCV) were first licensed for use with 3 primary doses ...